Articles about Gilead Sciences

American biopharmaceutical company Gilead has announced several steps to expand the availability of Remdesivir, which is a key therapeutic medicine used in the treatment of COVID-19 patients, in India.

The second worst-hit nation in coronavirus pandemic, India, that takes pride in the remarkable recovery rate, will reassess coronavirus treatment protocol after a large-scale trial conducted by World Health Organization (WHO) found that four commonly used re-purposed drugs had little impact in reducing mortality.

In a major development, Zydus Cadila has launched the cheapest generic version of Remdesivir, the antiviral drug being used to treat COVID-19, in India.

As the US Presidential election closes in, cyber-criminals are growing active on the mission to interfere with the campaign of the candidates.

At a Tuesday meeting to discuss India's drug discovery, testing, and vaccine response to COVID-19, Prime Minister Narendra Modi reportedly suggested drug regulatory reforms.

The US recently approved Remdesivir, a key antiviral drug from Gilead Sciences, for emergency use on COVID-19 patients.

The US government's top infectious disease expert, Dr. Anthony Fauci said that a new COVID-19 drug has proven to be quite a 'good news' in clinical trials.

The Ministry of Health and Family Welfare on Saturday said that 75% of all coronavirus-related deaths in India involved patients over the age of 60.

China is hoping to put a decade-old drug to use as it grapples with an outbreak of the deadly novel coronavirus disease, COVID-19.